(CATH) SP500 Catholic Values - Overview
Etf: Stocks, Us, Large-Cap, Catholic-Filtered
Dividends
| Dividend Yield | 0.87% |
| Yield on Cost 5y | 1.51% |
| Yield CAGR 5y | 3.27% |
| Payout Consistency | 98.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 14.5% |
| Relative Tail Risk | 4.07% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.60 |
| Alpha | -0.62 |
| Character TTM | |
|---|---|
| Beta | 0.983 |
| Beta Downside | 0.971 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.34% |
| CAGR/Max DD | 1.03 |
Description: CATH SP500 Catholic Values January 20, 2026
The Global X S&P 500® Catholic Values ETF (NASDAQ:CATH) seeks to track the S&P 500® Index while applying a values-screen that removes companies whose activities conflict with Catholic teachings as defined by the United States Conference of Catholic Bishops. At least 80 % of the fund’s assets must be invested in securities that comprise the underlying index, which contains up to roughly 500 U.S. large-cap stocks.
Key metrics (as of Q3 2024) show an expense ratio of 0.45 % and assets under management of approximately $150 million, with a turnover rate near 15 %-reflecting modest portfolio churn due to the static nature of the S&P 500 universe. The ETF’s sector exposure mirrors the broader index, but the screening process typically reduces weightings in health-care (by removing firms involved in abortion-related services) and consumer discretionary (by excluding gambling and alcohol producers), while maintaining a strong bias toward technology and industrials. Performance has historically trailed the unfiltered S&P 500 by about 0.5-1.0 percentage points annually, a trade-off investors accept for alignment with Catholic social values.
If you want a deeper quantitative view of how CATH’s risk-adjusted returns compare to conventional large-blend ETFs, a quick look at ValueRay’s analytics could be a useful next step.
What is the price of CATH shares?
Over the past week, the price has changed by -0.01%, over one month by -0.44%, over three months by +2.78% and over the past year by +14.66%.
Is CATH a buy, sell or hold?
What are the forecasts/targets for the CATH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 97 | 16.6% |
CATH Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.11b USD (1.11b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.11b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.11b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.54% (E(1.11b)/V(1.11b) * Re(9.54%) + (debt-free company))
Discount Rate = 9.54% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)